Accueil / Tag Archives: Pharmaceuticals & Biotechnology

Tag Archives: Pharmaceuticals & Biotechnology

Supernus Announces FDA Approval of sNDA to Expand Oxtellar XR® Label to Include Monotherapy

Supernus Pharmaceuticals, Inc. — Friday, December 14th 2018 at 9:02pm UTC ROCKVILLE, Md., Dec. 14, 2018 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (NASADQ: SUPN) announced today that the United States Food and Drug Administration (FDA) has approved the Company’s supplemental new drug application (sNDA) for Oxtellar XR®. The application requested …

Plus »

UPDATE – Retrotope Announces First Dosing of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD)

Retrotope — Friday, December 14th 2018 at 8:50pm UTC Two participating clinical trials centers now open for enrollment LOS ALTOS, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) — Retrotope announced today that it has begun enrollment of the first patients and has started dosing of infants with the ultra-rare neurodegenerative disease, …

Plus »

Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date

Apricus Biosciences, Inc. — Friday, December 14th 2018 at 5:30pm UTC The Meeting Seeking Stockholder Approval for Proposed Merger with Seelos Therapeutics, Inc. Will Be Reconvened on January 4, 2019 SAN DIEGO, Dec. 14, 2018 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (Nasdaq: APRI) has today convened and adjourned its special meeting …

Plus »

Axovant Sciences Announces Pricing of $30 Million Public Offering of Common Shares

Axovant Sciences Ltd. — Friday, December 14th 2018 at 2:00pm UTC BASEL, Switzerland, Dec. 14, 2018 (GLOBE NEWSWIRE) — Axovant Sciences (Nasdaq: AXON) (« Axovant ») today announced the pricing of its underwritten public offering of 30,000,000 of its common shares at a price to the public of $1.00 per share. Gross proceeds to …

Plus »

Diamond CBD, POTN Subsidiary Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules

PotNetwork Holding, Inc — Friday, December 14th 2018 at 2:54pm UTC Launching This New CBD-Infused Coffee Line, Company Brings Homes and Offices Nationwide an Enhanced and Chill Coffee Drinking Experience MIAMI, Fla., Dec. 14, 2018 (GLOBE NEWSWIRE) — via OTC PR WIRE — Diamond CBD Inc., wholly owned subsidiary of …

Plus »

Radient Technologies Inc. Ready to Serve $22B U.S. Market for Hemp-Derived CBD

Radient Technologies Inc — Friday, December 14th 2018 at 12:30pm UTC EDMONTON, Alberta, Dec. 14, 2018 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI) is encouraged by the approval by the U.S. Senate and House of Representatives of the 2018 Farm Bill (the “Farm Bill”), …

Plus »

Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency

Orchard Therapeutics — Friday, December 14th 2018 at 12:30pm UTC BOSTON and LONDON and MARTINSRIED, Germany, Dec. 14, 2018 (GLOBE NEWSWIRE) — Orchard Therapeutics (NASDAQ: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through innovative gene therapies, and SIRION …

Plus »

Sensorion Announces Positive Topline Results From Seliforant Phase 2a Study

Sensorion — Friday, December 14th 2018 at 6:30am UTC Results confirmed Seliforant does not affect vigilance, cognitive performance during a motion stimulus MONTPELLIER, France, Dec. 14, 2018 (GLOBE NEWSWIRE) — Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biopharmaceutical company, which specializes in the development of novel therapies to restore, treat …

Plus »

Genmab Announces Submission of Supplemental New Drug Application for Daratumumab in Front Line Multiple Myeloma in Japan

Genmab A/S — Friday, December 14th 2018 at 1:58am UTC Company Announcement Supplemental new drug application submitted in Japan for daratumumab in combination with bortezomib, melphalan and prednisone for the treatment of patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplant Submission based on data from Phase …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.